Abstract
Multivascular disease, indicating concurrent arteriosclerotic lesions in a number of different vascular beds, is an independent risk factor for recurrent ischemic events in the general population. However, the impact of multivascular disease on the risk of developing cardiovascular disease has not been fully evaluated in patients receiving hemodialysis. A total of 3,504 hemodialysis patients were prospectively followed for 10 years. In this study, multivascular disease was defined as the coexistence of coronary artery disease and stroke. We examined the relationship between multivascular disease and the occurrence of composite cardiovascular endpoint, consisting of cardiovascular death, nonfatal coronary artery disease, nonfatal stroke, and peripheral artery disease. The proportion of participants with multivascular disease was 5.7% (n=200) at baseline. During follow-up (median, 106.6 months; interquartile range, 50.1-121.8 months), 1,311 patients experienced the composite endpoint, which was defined as at least one of the following: cardiovascular death (n=620), nonfatal coronary artery disease (n=318), nonfatal stroke (n=340), and peripheral artery disease (n=257). Compared with the group with no history of cardiovascular dis...Continue Reading
References
May 24, 1997·Lancet·C J Murray, A D Lopez
Feb 5, 1999·The Australian and New Zealand Journal of Surgery·S W ChengJ Wong
Aug 12, 2003·European Heart Journal·Annemarie BeckerCoen D A Stehouwer
Mar 22, 2007·JAMA : the Journal of the American Medical Association·Ph Gabriel StegUNKNOWN REACH Registry Investigators
Dec 14, 2007·Acta chirurgica Belgica·L MissaultUNKNOWN OPERA Investigators Study Group
Dec 5, 2008·Atherosclerosis·Patrice P CacoubUNKNOWN REACH Registry Investigators
Apr 3, 2009·European Heart Journal·Deepak L BhattUNKNOWN CRUSADE Investigators
Jul 7, 2009·Deutsches Ärzteblatt International·Uwe ZeymerJoachim Röther
Oct 10, 2009·Journal of the Neurological Sciences·Shinichiro UchiyamaUNKNOWN REduction of Atherothrombosis for Continued Health Registry Investigators
Sep 2, 2010·JAMA : the Journal of the American Medical Association·Deepak L BhattUNKNOWN REACH Registry Investigators
Feb 19, 2011·International Journal of Nephrology·Panagiotis Pateinakis, Aikaterini Papagianni
Aug 1, 2014·Journal of Nephrology·Rieko EriguchiTakanari Kitazono
Jan 16, 2016·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Ikuto MasakaneKosaku Nitta
Aug 16, 2016·European Heart Journal·Nick TownsendMelanie Nichols
May 23, 2017·Cardiovascular Diagnosis and Therapy·Shanthi Mendis
Jul 5, 2017·Journal of Atherosclerosis and Thrombosis·Kentaro WatanabeShinichi Nishi
Jan 26, 2018·Journal of Atherosclerosis and Thrombosis·Ryuta ItoToyoaki Murihara
May 2, 2018·Journal of Atherosclerosis and Thrombosis·Rine Nakanishi, Takanori Ikeda
Dec 24, 2018·Medicine·Masatoshi HaraTakanari Kitazono
Feb 2, 2019·Scientific Reports·Shigeru TanakaTakanari Kitazono
May 8, 2019·Journal of Atherosclerosis and Thrombosis·Hiroshi SonodaAkiko Tamakoshi
Aug 23, 2019·Journal of Atherosclerosis and Thrombosis·Hiroto HiyamutaTakanari Kitazono
Aug 30, 2019·Journal of Atherosclerosis and Thrombosis·Xiaowei SongJian Wu
Nov 7, 2019·Journal of Atherosclerosis and Thrombosis·Nobuhiko JokiToshihide Hayashi
Nov 9, 2019·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Toshiaki NakanoTakanari Kitazono